BRIDGEBIO PHARMA INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BRIDGEBIO PHARMA INC NOTE 2.500% 3/1, CUSIP 10806XAB8.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BRIDGEBIO PHARMA INC NOTE 2.500% 3/1, CUSIP 10806XAB8.